These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1068 related articles for article (PubMed ID: 3994311)

  • 1. Immune functions in melanoma patients during treatment with interferon [HuIFN-alpha (Le)] alone or in combination with cimetidine.
    Flodgren P; Malmström P; Axelsson B; Boketoft A; Borgström S; Sjögren HO
    Anticancer Res; 1985; 5(2):197-204. PubMed ID: 3994311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of human leukocyte interferon (HuIFN-alpha/Le/) and cimetidine on the proliferation of cultured melanoma cells in vitro.
    Flodgren P
    Anticancer Res; 1985; 5(5):527-31. PubMed ID: 4062254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study on the effects of recombinant alpha-2 interferon on immune function in patients with disseminated melanoma.
    Hersey P; Coates A; Rallings M; Hall C; MacDonald M; Spurling A; Edwards A; McCarthy WH; Milton GW
    J Biol Response Mod; 1986 Jun; 5(3):236-49. PubMed ID: 3487622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic administration of human leukocyte interferon to melanoma patients. III. Increased helper:suppressor cell ratios in melanoma patients during interferon treatment.
    Karavodin LM; Golub SH
    Nat Immun Cell Growth Regul; 1983-1984; 3(4):193-202. PubMed ID: 6241293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of fibroblast interferon (HuIFN beta), carboxamide (DTIC), and cimetidine for advanced malignant melanoma.
    Abdi EA; McPherson TA; Tan YH
    J Biol Response Mod; 1986 Oct; 5(5):423-8. PubMed ID: 3772395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma.
    de Gast GC; Klümpen HJ; Vyth-Dreese FA; Kersten MJ; Verra NC; Sein J; Batchelor D; Nooijen WJ; Schornagel JH
    Clin Cancer Res; 2000 Apr; 6(4):1267-72. PubMed ID: 10778950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation of natural immunity and correlation with tumor response in melanoma patients treated with human lymphoblastoid interferon.
    Neefe JR; Phillips EA; Treat J
    Diagn Immunol; 1986; 4(6):299-305. PubMed ID: 3102149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-interferons in malignant melanoma.
    McLeod GR
    Br J Clin Pract Suppl; 1988 Mar; 62():22-6. PubMed ID: 3145011
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of cimetidine on natural killer activity of peripheral blood lymphocytes of patients with ovarian carcinoma.
    Kikuchi Y; Oomori K; Kizawa I; Kato K
    Jpn J Clin Oncol; 1985 Jun; 15(2):377-83. PubMed ID: 3839542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of recombinant interferon alpha 2 and cimetidine in patients with advanced malignant melanoma.
    Mughal TI; Robinson WA; Thomas MR; Spiegel R
    J Cancer Res Clin Oncol; 1988; 114(1):108-9. PubMed ID: 3350837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in immunological parameters after combination adjuvant therapy with intravenous DTIC, ACNU, and VCR, and local injection of IFN-beta (DAV + IFN-beta therapy) into malignant melanoma.
    Umeda T; Aoki K; Yokoyama A; Ohara H; Hayashi O; Tanaka K; Nishioka K
    J Dermatol; 1998 Sep; 25(9):569-72. PubMed ID: 9798342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The function of the immune system after the treatment of pediatric malignant diseases].
    Gadó J; Schlick B; Bárány O; Németh J; Müller J; Csóka M; Constantin T; Vonnák E; Böcskei R; Hauser P; Kovács G
    Orv Hetil; 2006 Sep; 147(36):1731-8. PubMed ID: 17087017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of R24 monoclonal antibody and low-dose interleukin 2 for malignant melanoma.
    Soiffer RJ; Chapman PB; Murray C; Williams L; Unger P; Collins H; Houghton AN; Ritz J
    Clin Cancer Res; 1997 Jan; 3(1):17-24. PubMed ID: 9815532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant leukocyte A interferon as single agent therapy or in combination with cimetidine in patients with advanced colo-rectal carcinoma. A phase II investigation.
    Flodgren P; Hugander A; Sjögren HO
    Acta Radiol Oncol; 1985; 24(1):25-34. PubMed ID: 2984899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interferon therapy effects on activation of T-lymphocytes in patients with systemic lupus erythematosus].
    Stanislav ML; Balabanova RM; Nikonova MF; Litvina MM; Iarilin AA
    Ter Arkh; 2000; 72(5):44-9. PubMed ID: 11109620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of therapeutic and immunologic effects of R(24) anti-GD3 monoclonal antibody in 37 patients with metastatic melanoma.
    Kirkwood JM; Mascari RA; Edington HD; Rabkin MS; Day RS; Whiteside TL; Vlock DR; Shipe-Spotloe JM
    Cancer; 2000 Jun; 88(12):2693-702. PubMed ID: 10870051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic malignant melanoma: regression induced by combined treatment with interferon [HuIFN-alpha(Le)] and cimetidine.
    Flodgren P; Borgström S; Jönsson PE; Lindström C; Sjögren HO
    Int J Cancer; 1983 Dec; 32(6):657-65. PubMed ID: 6654521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic implications of the kinetics of immunomodulation during single or combined treatment of melanoma patients with dacarbazine and interferon-alpha.
    Konjević G; Jović V; Radulović S; Jelić S; Dzodić R; Spuzić I
    Neoplasma; 2001; 48(3):175-81. PubMed ID: 11583285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous interleukin-2 and interferon-alpha plus cisplatin with and without prophylactic cimetidine in patients with metastatic malignant melanoma: a phase II study.
    Schmidt H; Geertsen PF; Fode K; Rytter C; Bastholt L; von der Maase H
    Melanoma Res; 2000 Feb; 10(1):66-77. PubMed ID: 10711642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential applications of the interferons in oncology: lessons drawn from studies of human melanoma.
    Kirkwood JM; Ernstoff M
    Semin Oncol; 1986 Sep; 13(3 Suppl 2):48-56. PubMed ID: 3532336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.